skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,085  for All Library Resources

Sorted by: Sorted by: PopularityOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Predictors and outcomes of recurrent retroperitoneal liposarcoma: new insights into its recurrence patterns
Predictors and outcomes of recurrent retroperitoneal liposarcoma: new insights into its recurrence patterns
Material Type:
Article 		Add to My Research

Predictors and outcomes of recurrent retroperitoneal liposarcoma: new insights into its recurrence patterns

BMC cancer, 2023-11, Vol.23 (1), p.1076-1076, Article 1076 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11586-8

Full text available

Citations Cited by
2
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential
Material Type:
Article 		Add to My Research

A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential

BMC cancer, 2019-06, Vol.19 (1), p.581-581, Article 581 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5768-0 ;PMID: 31200666

Full text available

Citations Cited by
3
Clinical effects of curcumin in enhancing cancer therapy: A systematic review
Clinical effects of curcumin in enhancing cancer therapy: A systematic review
Material Type:
Article 		Add to My Research

Clinical effects of curcumin in enhancing cancer therapy: A systematic review

BMC cancer, 2020-08, Vol.20 (1), p.791-11, Article 791 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07256-8 ;PMID: 32838749

Full text available

Citations Cited by
4
Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort
Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort
Material Type:
Article 		Add to My Research

Development of a well-defined tool to predict the overall survival in lung cancer patients: an African based cohort

BMC cancer, 2023-10, Vol.23 (1), p.1016-1016, Article 1016 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11355-7 ;PMID: 37864151

Full text available

Citations Cited by
5
Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
Material Type:
Article 		Add to My Research

Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study

BMC cancer, 2021-11, Vol.21 (1), p.1-1191, Article 1191 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08848-8 ;PMID: 34753434

Full text available

Citations Cited by
6
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Material Type:
Article 		Add to My Research

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

BMC cancer, 2017-05, Vol.17 (1), p.332-332, Article 332 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3286-5 ;PMID: 28511673

Full text available

Citations Cited by
7
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients
Material Type:
Article 		Add to My Research

Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients

BMC cancer, 2021-05, Vol.21 (1), p.1-645, Article 645 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08341-2 ;PMID: 34059009

Full text available

Citations Cited by
8
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019
Material Type:
Article 		Add to My Research

Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019

BMC cancer, 2021-05, Vol.21 (1), p.1-606, Article 606 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08280-y ;PMID: 34034700

Full text available

Citations Cited by
9
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years
Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years
Material Type:
Article 		Add to My Research

Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years

BMC cancer, 2022-07, Vol.22 (1), p.1-836, Article 836 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09940-3 ;PMID: 35907848

Full text available

Citations Cited by
10
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
Material Type:
Article 		Add to My Research

Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice

BMC cancer, 2019-02, Vol.19 (1), p.151-151, Article 151 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5354-5 ;PMID: 30764783

Full text available

Citations Cited by
11
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
Material Type:
Article 		Add to My Research

PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer

BMC cancer, 2015-08, Vol.15 (1), p.602, Article 602 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Owadally et al. 2015 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-015-1598-x ;PMID: 26311526

Full text available

Citations Cited by
12
Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma
Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma
Material Type:
Article 		Add to My Research

Prognostic impact of pretreatment skeletal muscle index and CONUT score in diffuse large B-cell Lymphoma

BMC cancer, 2023-11, Vol.23 (1), p.1071-1071, Article 1071 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11590-y ;PMID: 37932700

Full text available

Citations Cited by
13
The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma
The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma
Material Type:
Article 		Add to My Research

The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma

BMC cancer, 2023-10, Vol.23 (1), p.1045-1045, Article 1045 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11558-y ;PMID: 37904131

Full text available

Citations Cited by
14
Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
Material Type:
Article 		Add to My Research

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma

BMC cancer, 2021-05, Vol.21 (1), p.1-622, Article 622 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08373-8 ;PMID: 34044810

Full text available

Citations Cited by
15
Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map
Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map
Material Type:
Article 		Add to My Research

Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map

BMC cancer, 2023-06, Vol.23 (1), p.544-544, Article 544 [Peer Reviewed Journal]

2023. The Author(s). ;COPYRIGHT 2023 BioMed Central Ltd. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11043-6 ;PMID: 37316802

Full text available

Citations Cited by
16
A convolutional neural network-based system to classify patients using FDG PET/CT examinations
A convolutional neural network-based system to classify patients using FDG PET/CT examinations
Material Type:
Article 		Add to My Research

A convolutional neural network-based system to classify patients using FDG PET/CT examinations

BMC cancer, 2020-03, Vol.20 (1), p.227-227, Article 227 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-6694-x ;PMID: 32183748

Full text available

Citations Cited by
17
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
Material Type:
Article 		Add to My Research

Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

BMC cancer, 2015-10, Vol.15 (1), p.767-767, Article 767 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Smith et al. 2015 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-015-1632-z ;PMID: 26497495

Full text available

Citations Cited by
18
Radiographic and [alpha]-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study
Radiographic and [alpha]-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study
Material Type:
Article 		Add to My Research

Radiographic and [alpha]-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study

BMC cancer, 2023-05, Vol.23 (1) [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10898-z

Full text available

Citations Cited by
19
Upregulation of pERK and c-JUN by [gamma]-tocotrienol and not [alpha]-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells
Upregulation of pERK and c-JUN by [gamma]-tocotrienol and not [alpha]-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells
Material Type:
Article 		Add to My Research

Upregulation of pERK and c-JUN by [gamma]-tocotrienol and not [alpha]-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells

BMC cancer, 2020-05, Vol.20 (1) [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06947-6

Full text available

Citations Cited by
20
A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01
A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01
Material Type:
Article 		Add to My Research

A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01

BMC cancer, 2019-12, Vol.19 (1), p.1250-1250, Article 1250 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6442-2 ;PMID: 31881853

Full text available

Citations Cited by

Results 1 - 20 of 1,085  for All Library Resources

Sorted by: Sorted by: PopularityOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2012  (4)
  2. 2012 To 2015  (248)
  3. 2016 To 2018  (50)
  4. 2019 To 2022  (645)
  5. After 2022  (139)
  6. More options open sub menu

Subject 

  1. Medical Research  (1,080)
  2. Medicine, Experimental  (1,079)
  3. Oncology  (1,019)
  4. Life Sciences & Biomedicine  (1,014)
  5. Science & Technology  (1,014)
  6. Humans  (755)
  7. Cancer  (612)
  8. Care And Treatment  (589)
  9. Female  (535)
  10. Analysis  (534)
  11. Prognosis  (490)
  12. Patients  (426)
  13. Health Aspects  (425)
  14. Middle Aged  (414)
  15. Male  (397)
  16. Metastasis  (394)
  17. Tumors  (371)
  18. Aged  (344)
  19. Chemotherapy  (329)
  20. Medical Prognosis  (309)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait